HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Julie M Janssen Selected Research
Julie M Janssen Research Topics
Disease
5
Neoplasms (Cancer)
01/2021 - 11/2017
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
2
Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2019
1
Disease Progression
01/2022
1
Infertility (Sterility)
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1
Critical Illness (Critically Ill)
10/2017
Drug/Important Bio-Agent (IBA)
2
Docetaxel (Taxotere)
FDA Link
01/2021 - 01/2021
2
Phosphotransferases (Kinase)
IBA
01/2020 - 12/2018
1
ErbB Receptors (EGF Receptor)
IBA
01/2022
1
Circulating Tumor DNA
IBA
01/2022
1
alectinib
IBA
01/2021
1
Crizotinib
IBA
01/2021
1
Anaplastic Lymphoma Kinase
IBA
01/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021
1
Epirubicin (Ellence)
FDA Link
Generic
01/2021
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2021
1
Ritonavir (Norvir)
FDA Link
01/2021
1
Bortezomib (Velcade)
FDA Link
01/2020
1
abiraterone
IBA
10/2019
1
Gentamicins (Gentamicin)
FDA Link
Generic
10/2017
Therapy/Procedure
2
Castration
01/2021 - 10/2019
1
Investigational Therapies (Experimental Therapy)
11/2017